Kevin Ling
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Glycosylation and Glycoproteins Research 1
- Melanoma and MAPK Pathways 1
-
- Polymer Surface Interaction Studies 2
- Co-authors
- Julie A. Champion (3 shared papers)Huixia Wu (2 shared papers)Andrew S. Neish (2 shared papers)Arun Das (1 shared paper)Steven L. Waslander (1 shared paper)Lauren S. Sefcik (1 shared paper)Charles A. Parkos (1 shared paper)Jean‐François Lutz (1 shared paper)
- Journals
- Cellular and Molecular Bioengineering (1 paper)Advanced Science (1 paper)ACS Nano (1 paper)Heliyon (1 paper)Blood (1 paper)
- Partner nations
- United StatesChinaHong Kong
In The Last Decade
Kevin Ling
8 papers receiving 300 citations
Peers
Comparison fields: 5 of 81
- Pharmaceutical Science 65
- Biomaterials 115
- Molecular Medicine 22
- Surfaces, Coatings and Films 32
- Biomedical Engineering 75
Countries citing papers authored by Kevin Ling
This map shows the geographic impact of Kevin Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Ling more than expected).
Fields of papers citing papers by Kevin Ling
This network shows the impact of papers produced by Kevin Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Ling. The network helps show where Kevin Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Kevin Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 128 | |
| 2 | 2018 | 101 | |
| 3 | 2017 | 27 | |
| 4 | 2014 | 18 | |
| 5 | 2013 | 15 | |
| 6 | 2023 | 9 | |
| 7 | 2015 | 4 | |
| 8 | 2023 | 2 | |
| 9 | 2025 | 0 | |
| 10 | 2025 | 0 |
About Kevin Ling
Kevin Ling is a scholar working on Molecular Biology, Surfaces, Coatings and Films, Biomedical Engineering, Infectious Diseases and Surgery, having authored 10 papers that have together received 304 indexed citations. Recurring topics across this work include Polymer Surface Interaction Studies (2 papers), Glycosylation and Glycoproteins Research (1 paper), NF-κB Signaling Pathways (1 paper), Melanoma and MAPK Pathways (1 paper), Underwater Vehicles and Communication Systems (1 paper), Cystic Fibrosis Research Advances (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Antimicrobial Peptides and Activities (1 paper). The work is most often cited by research in Pharmaceutical Science (65 citations), Biomaterials (115 citations), Molecular Medicine (22 citations), Surfaces, Coatings and Films (32 citations) and Biomedical Engineering (75 citations). Kevin Ling has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Julie A. Champion, Huixia Wu, Andrew S. Neish, Arun Das, Steven L. Waslander, Lauren S. Sefcik, Charles A. Parkos, Jean‐François Lutz, Rheinallt M. Jones and Erik Wischerhoff. Their work appears in journals such as Cellular and Molecular Bioengineering, Advanced Science, ACS Nano, Heliyon and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.